1. Effect of miR-155 knockdown on the reversal of doxorubicin resistance in human lung cancer A549/dox cells
    LIXIA LV et al, 2016, Oncology Letters CrossRef
  2. 2,4,6-Tribromophenol Exposure Decreases P-Glycoprotein Transport at the Blood-Brain Barrier
    Andrew W Trexler et al, 2019, Toxicological Sciences CrossRef
  3. Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment
    Ya‐Ping Liu et al, 2021, MedComm CrossRef
  4. UBE2C Is a Potential Biomarker of Intestinal-Type Gastric Cancer With Chromosomal Instability
    Jun Zhang et al, 2018, Frontiers in Pharmacology CrossRef
  5. ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer
    Iris C. Salaroglio et al, 2019, International Journal of Molecular Sciences CrossRef
  6. TIPE2 sensitizes osteosarcoma cells to cis-platin by down-regulating MDR1 via the TAK1- NF-κB and - AP-1 pathways
    Peiqing Zhao et al, 2018, Molecular Immunology CrossRef
  7. K-Ras-ERK1/2 accelerates lung cancer cell development via mediating H3K18ac through the MDM2-GCN5-SIRT7 axis
    Ziming Cheng et al, 2019, Pharmaceutical Biology CrossRef
  8. Pt(iv) anticancer prodrugs bearing an oxaliplatin scaffold: what do we know about their bioactivity?
    Alvaro Lopez-Sanchez et al, 2024, Inorganic Chemistry Frontiers CrossRef
  9. RETRACTED ARTICLE: Lymphatic metastasis-related TBL1XR1 enhances stemness and metastasis in gastric cancer stem-like cells by activating ERK1/2-SOX2 signaling
    Jun Lu et al, 2021, Oncogene CrossRef
  10. Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review
    Guadalupe Rosario Fajardo-Orduña et al, 2021, International Journal of Molecular Sciences CrossRef
  11. Role of microRNAs in drug resistance of gastric cancer cells
    Bi-Bo Tan et al, 2019, World Chinese Journal of Digestology CrossRef
  12. Arsenic trioxide attenuates STAT-3 activity and epithelial-mesenchymal transition through induction of SHP-1 in gastric cancer cells
    Sung Ho Kim et al, 2018, BMC Cancer CrossRef
  13. A systematic review and meta-analysis of bidirectional effect of arsenic on ERK signaling pathway
    Dongjie Li et al, 2018, Molecular Medicine Reports CrossRef
  14. Arsenic trioxide potentiates the effectiveness of etoposide in Ewing sarcomas
    Karen A. Boehme et al, 2016, International Journal of Oncology CrossRef
  15. Role of microRNAs in regulation of doxorubicin and paclitaxel responses in lung tumor cells
    Amirhosein Maharati et al, 2023, Cell Division CrossRef
  16. RETRACTED ARTICLE: K-ras-ERK1/2 down-regulates H2A.XY142ph through WSTF to promote the progress of gastric cancer
    Chao Dong et al, 2019, BMC Cancer CrossRef
  17. The ATO/miRNA-885-5p/MTPN axis induces reversal of drug-resistance in cholangiocarcinoma
    Yuting Wang et al, 2021, Cellular Oncology CrossRef
  18. Interaction Analysis of MRP1 with Anticancer Drugs Used in Ovarian Cancer: In Silico Approach
    Absarul Haque et al, 2022, Life CrossRef
  19. Research progress on arsenic, arsenic-containing medicinal materials, and arsenic-containing preparations: clinical application, pharmacological effects, and toxicity
    Yichu Yang et al, 2024, Frontiers in Pharmacology CrossRef

  20. Multidrug Resistance of Gastric Cancer: The Mechanisms and Chinese Medicine Reversal Agents


    Wen-Jie Huang et al, 2020, Cancer Management and Research CrossRef
  21. Pharmacokinetic herb-drug interactions between Aidi injection and doxorubicin in rats with diethylnitrosamine-induced hepatocellular carcinoma
    Yuan Lu et al, 2021, BMC Pharmacology and Toxicology CrossRef